The Scientific World Journal

The Scientific World Journal / 2008 / Article
Special Issue

Hemaglobinopathies

View this Special Issue

Review | Open Access

Volume 8 |Article ID 798678 | https://doi.org/10.1100/tsw.2008.157

Martin H. Steinberg, "Sickle Cell Anemia, the First Molecular Disease: Overview of Molecular Etiology, Pathophysiology, and Therapeutic Approaches", The Scientific World Journal, vol. 8, Article ID 798678, 30 pages, 2008. https://doi.org/10.1100/tsw.2008.157

Sickle Cell Anemia, the First Molecular Disease: Overview of Molecular Etiology, Pathophysiology, and Therapeutic Approaches

Academic Editor: Susan Perrine
Received15 Jul 2008
Revised24 Oct 2008
Accepted10 Dec 2008

Abstract

The root cause of sickle cell disease is a single β-globin gene mutation coding for the sickle β-hemoglobin chain. Sickle hemoglobin tetramers polymerize when deoxygenated, damaging the sickle erythrocyte. A multifaceted pathophysiology, triggered by erythrocyte injury induced by the sickle hemoglobin polymer, and encompassing more general cellular and tissue damage caused by hypoxia, oxidant damage, inflammation, abnormal intracellular interactions, and reduced nitric oxide bioavailability, sets off the events recognized clinically as sickle cell disease. This disease is a group of related disorders where sickle hemoglobin is the principal hemoglobin species. All have varying degrees of chronic hemolytic anemia, vasculopathy, vasoocclusive disease, acute and chronic organ damage, and shortened life span. Its complex pathophysiology, of which we have a reasonable understanding, provides multiple loci for potential therapeutic intervention.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views3452
Downloads14146
Citations

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.